Ken Herrmann

Congratulations to the PCWG4 panel! #GU26 @JCO_ASCO @ASCO @AarmstrongDuke @DrRanaMcKay @morris @DrScottTagawa and many more ascopubs.org/doi/pdfdirect/…

Just Published at @JCO_ASCO and out for #GU26 POSTER NOW BEING PRESENTED 11:30-12:45pm ABSTRACT 162 Poster Bd E17 (Please Visit) Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4 👉ascopubs.org/doi/10.1200/JC… Here is Dr Michael Morris🇺🇸from @MSKCancerCenter to tell us more #ProstateCancer @DrRanaMcKay Michael J. Morris @EAntonarakis @AarmstrongDuke @mishabeltran @drlouiseemmett @ProfKHerrmann @DrMHofman @JoshLangMD @CaPsurvivorship @Cpaller @cnsternberg

Just Published at @JCO_ASCO and out for #GU26 Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4 ascopubs.org/doi/10.1200/JC… Here is Dr Andrew Armstrong🇺🇸 @AarmstrongDuke to tell us more #ProstateCancer @DrRanaMcKay Michael J. Morris @EAntonarakis @mishabeltran @drlouiseemmett @ProfKHerrmann @DrMHofman @JoshLangMD @CaPsurvivorship @Cpaller @cnsternberg

Colleagues at #GU26 ,A reminder that #APCCC26 🇨🇭is coming in 2026 This is a Conference is OPEN TO EVERYONE, not just the Panel members and EARLY REGISTRATION is up until February 28, 2026 👉️ REGISTER HERE: buff.ly/XpCWPdR Only 🔟 days left until the Early Bird deadline (28 February 2026) Enjoy 20% off when registering for both APCCC & IPCS 2026 Awarm invite to the Advanced Prostate Cancer Consensus Conference #APCCC26 in Lugano🇨🇭 Event Details: 📍 Palazzo Congressi, Lugano, Switzerland 🎟️ Register here 🎓 Credits requests: SGU – SSU, SSMO, SRO, SGMN In an era of rapid innovation and expanding treatment options for advanced #ProstateCancer , APCCC provides a vital forum for clinicians and researchers to address complex clinical questions where high-level evidence is limited. Over two days, the world’s leading experts will engage in high-level presentations, debates, and discussions to clarify and conceptualize the current landscape of care, with a focus on areas of controversy or uncertainty. The insights and consensus developed during the meeting are later published in European Urology, helping shape global standards. Creating new opportunities for younger investigators & the next generation of leaders in advanced prostate cancer! @Silke_Gillessen & @AOmlin @fabioturco92 @Prof_IanD @drjefstathiou @Prof_Nick_James @ChrisSweens1 @BertrandTOMBAL @ZilliThomas @neerajaiims @bjartell @PBlanchardMD @BourlonMaite @Albert0Briganti @cdanicas @Ecastromarcos @mdesantis234 @nachoduranm @drlouiseemmett @stefanofanti4 @fontev1 @Nicola_Fossati @marty_gleave @ProfKHerrmann @DrMHofman @BarbaraJereczek @ravikanesvaran @FacsRaja @LoebStacy @quimmateo @DrRanaMcKay @amerseburger @CaPsurvivorship @declangmurphy @DrPaulNguyen @WilliamOhMD @piet_ost @DrSpratticus @cnsternberg @DrYukselUrun Ping @nataliagandur @OncoAlert 🚨

A major step forward for precision medicine today. Peter Mac has installed cutting-edge @GEHealthCare total body PET/CT technology — supported by $15M in new grants and funding.

Dear Colleagues at #ESMO25 An honor to present our faculty🚨 @Silke_Gillessen and @AOmlin straight from Berlin who discuss about: The Radioligand Therapy Session on #ProstateCancer VERY hot Topics and some that will spark up conversation in Lugano🇨🇭 for #APCCC26 @APCCC_Lugano @montypal @crisbergerot @DrDanielHeng @apolo_andrea @DrChoueiri @PGrivasMDPhD @TiansterZhang @HHammersMD @ravikanesvaran @neerajaiims @amerseburger @sonpavde @drenriquegrande @scserendipity1 @Silke_Gillessen @EfstathiouEleni @tompowles1 @BraunMDPhD @nataliagandur @cdanicas @bavilima @yekeduz_emre @DrYukselUrun @TylerSbrt @mgmglobal @LoebStacy @piet_ost @_ShankarSiva @seanmmcbride